Self-expanding metal stents (SEMS) for patients with advanced Esophageal cancer in Malawi: An effective palliative treatment

Journal of Surgical Oncology

Volumn 105, Issue 4, 2012, Pages 410-414

  Thumbs, Alexander ^a   Borgstein, Eric ^a   Vigna, Leo ^b   Kingham, T Peter ^c,d   Kushner, Adam L ^c,e   Hellberg, Kai ^a   Bates, Jane ^f   Wilhelm, Torsten J ^g,h  

^a UNIVERSITY OF MALAWI   (Malawi)

^b Mwaiwathu Private Hospital   (Malawi)

^c Surgeons OverSeas   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

^g Zomba Central Hospital   (Malawi)

^h UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

esophageal carcinoma; palliation; resource limited countries; rural Africa; stenting

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CARCINOMA IN SITU; DYSPHAGIA; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS PERFORATION; FEMALE; FOLLOW UP; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALAWI; MALE; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; RISK FACTOR; SCORING SYSTEM; SELF EXPANDING METAL STENT; STENT; SURVIVAL TIME; THORAX DRAINAGE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALAWI; MALE; METALS; MIDDLE AGED; PALLIATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STENTS; SURVIVAL RATE;

EID: 84857036467     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23003     Document Type: Article

References (37)

1. Lagergren J, Lagergren P:, Oesophageal cancer. BMJ 2010; 341: c6280. DOI: 10.1136/bmj.c6280.
2. Parkin DM, Pisani P, Ferlay J:, Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606. (Pubitemid 23188190)
3. Gatei DG, Odhiambo PA, Orinda DA, et al.: A retrospective study of carcinoma of the esophagus in Kenya. Cancer Res 1978; 38: 303-307. (Pubitemid 8283949)
4. Burkitt DP, Standfield JP, Church JP:, A medical research safari: Fruits and frustrations. Cent Afr J Med 1970; 16: 197-201.
5. Pickens A, Orringer MB:, Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg 2003; 76: 1367-1369.
6. Pfau PR, Ginsberg GG, Lew RJ, et al.: Esophageal dilatation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol 2000; 95: 2813-2815.
7. Thumbs A, Borgstein E:, Commentary: Managing esophageal cancer in a resource poor settingA Malawian example. BMJ 2010; 341: c6723. DOI: 10.1136/bmj.c6723.
8. De Palma GD, Galloro G, Sivero L, et al.: Self-expanding metal stents for palliation of inoperable carcinoma of the esophagus and gastroesophageal junction. Am J Gastroenterol 1995; 90: 2140-2142.
9. White RE, Parker RK, Fitzwater JW, et al.: Stents as sole therapy for esophageal cancer: A prospective analysis of outcomes after placement. Lancet Oncol 2009; 10: 240-246.
10. White RE, Mungatana C, Topazian M:, Esophageal stent placement without fluoroscopy. Gastrointest Endosc 2001; 53: 348-351. (Pubitemid 32207326)
11. Cwikiel W, Stridbeck H, Tranberg KG, et al.: Malignant esophageal strictures: Treating with a self-expanding nitinol stent. Radiology 1993; 187: 661-665. (Pubitemid 23155690)
12. Adam A, Ellul J, Watkinson AF, et al.: Palliation of inoperable esophageal carcinoma: A prospective randomized trial of laser therapy and stent placement. Radiology 1997; 202: 344-348. (Pubitemid 27051723)
13. Siersema PD, Hop WC, van Blankenstein M, et al.: A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: A prospective, randomized study. Gastrointest Endosc 2001; 54: 145-153.
14. Mayoral W, Fleischer D, Salcedo J, et al.: Non-malignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc 2000; 51: 556-559. (Pubitemid 30322339)
15. Sreedharan A, Harris K, Crellin A, et al.: Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 2009; (4):CD005048.
16. Homs MY, Steyerberg EW, Eijkenboom WM, et al.: Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from esophageal cancer: Multicentre randomized trial. Lancet 2004; 364: 1497-1504. (Pubitemid 39410415)
17. Vakil N, Morris AI, Marcon N, et al.: A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 2001; 96: 1791-1796.
18. Xinopoulos D, Dimitroulopoulos D, Tsamakidis K, et al.: Palliative treatment of advanced esophageal cancer with metal-covered expandable stents. A cost-effectiveness and quality of life study. J BUON 2005; 10: 523-528. (Pubitemid 43285558)
19. Johnson E, Enden T, Noreng HJ, et al.: Survival and complications after insertion of self-expandable metal stents for malignant oesophageal stenosis. Scand J Gastroenterol 2006; 41: 252-256.
20. Christie NA, Buenaventura PO, Fernando HC, et al.: Results of expandable metal stents for malignant esophageal obstruction in 100 patients: Short-term and long-term follow-up. Ann Thorac Surg 2001; 71: 1797-1801.
21. Litle VR, Luketich JD, Christie NA, et al.: Photodynamic therapy as palliation for esophageal cancer: Experience in 215 patients. Ann Thorac Surg 2003; 76: 1687-1693. (Pubitemid 37378339)
22. Dallal HJ, Smith GD, Grieve DC, et al.: A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001; 54: 549-557. (Pubitemid 33666025)
23. Sur RK, Levin VC, Donde B, et al.: Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinomaAn International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys 2002; 53: 127-133. (Pubitemid 34465815)
24. Banda LT, Parkin DM, Dzamalala CP, et al.: Cancer incidence in Blantyre, Malawi 1994-1998. Trop Med Int Health 2001; 6: 296-304. (Pubitemid 32385855)
25. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
26. Wu AH, Wan P, Bernstein L:, A multiethnic population-based study of smoking, alcohol and body size and risk of carcinoma of the stomach and esophagus. Cancer Causes Control 2001; 12: 721-723.
27. Fan Y, Yuan JM, Wang R, et al.: Alcohol, tobacco and diet in relation to esophageal cancer. The Shanghai cohort study. Nutr Cancer 2008; 60: 354-363. (Pubitemid 351601371)
28. Abedi-Ardekani B, Kamangar F, Hewitt SM, et al.: Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut 2010; 59: 1178-1183.
29. Sammon A:, Squamous cancer of the esophagus in Africa. Published at, 2009.
30. Chang F, Syrjänen S, Shen Q, et al.: Detection of HPV DNA in oesophageal squamous cell carcinoma from the high-incidence area of Linxian, China. Scand J Gastroenterol 2000; 35: 123-130.
31. Astori G, Merluzzi S, Arzese A, et al.: Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. Digestion 2001; 64: 9-14. (Pubitemid 32830547)
32. Trottier AM, Coutlee F, Leduc R, et al.: Human immunodeficiency virus infection is a major risk factor for detection of human papillomavirus DNA in esophageal brushings. Clin Infect Dis 1997; 24: 565-569. (Pubitemid 27143548)
33. Pillai M, Nair M:, Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors. Exp Mol Pathol 2000; 69: 233-241. (Pubitemid 32006303)
34. Syrjänen KJ:, HPV infections and oesophageal cancer. J Clin Pathol 2002; 55: 721-728. (Pubitemid 35231898)
35. Franceschi S, Munoz N, Bosch XF, et al.: Human papillomavirus and cancers of the upper aerodigestive tract: A review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996; 5: 567-575. (Pubitemid 26235024)
36. Dreilich M, Bergqvist M, Moberg M, et al.: High-risk human papillomavirus (HPV) and survival in patients with esophageal carcinoma: A pilot study. BMC Cancer 2006; 6: 94. DOI: 10.1186/1471-2407-6-94. (Pubitemid 43842141)
37. Motti PG, Dallabetta GA, Daniel RW, et al.: Cervical abnormalities, human papillomavirus, and human virus infections in women in Malawi. J Infect Dis 1996; 173: 714-717. (Pubitemid 26064073)